| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Center for Cardiovascular Research, Department of Physiology and Biophysics (D.U., L.A.W., R.J.S., B.M.W.) and Department of Medicine (F.A.L.D., J.R.P., L.A.W., B.M.W.), Section of Cardiology, University of Illinois at Chicago.
Correspondence to Dr Beata M. Wolska, University of Illinois at Chicago, Dept of Medicine, Section of Cardiology, 840 S Wood St (M/C 715), Chicago, IL 60612. E-mail bwolska{at}uic.edu
| Abstract |
|---|
|
|
|---|
Key Words: troponin I hypercapnia acidosis
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Echocardiography
Transthoracic 2D-targeted M-mode and pulsed Doppler echocardiography (ECHO) were performed with a 15-MHz linear array transducer (Acuson Sequoia C256 system). The transducer was placed on a layer of acoustic coupling gel that was applied to the left hemithorax; adequate contact was maintained while avoiding excessive pressure on the chest. Mice were imaged in a shallow left lateral decubitus position. M-mode images of the left ventricle were obtained from the parasternal short axis view at the level of the papillary muscles. Interventricular septal and LV posterior wall thicknesses and LV internal dimensions at the end of diastole and systole were measured by the American Society of Echocardiography leading-edge method on the M-mode tracings.16 Fractional shortening of the left ventricle, a measure of LV systolic function, was calculated from digital images as: LV fractional shortening (FS) (FS) (%)=(LVIDdLVISd)/LVIDdx100, where LVIDd is the internal diastolic dimension of the LV, and LVISd is the internal systolic dimension of the LV.17
Diastolic transmitral inflow recordings were acquired from apical four-chamber view using 7 MHz pulsed Doppler ECHO. The probe was positioned substernally at the xyphoid applying minimal pressure. The Doppler range gate depth was set at 4 mm to obtain optimal signals from the LV inflow and outflow tracks. The sample volume was positioned along the long axis in the middle of the mitral ring at the tips of the opened cusps of the mitral valve. Three parameters of the LV diastolic function were evaluated: (1) E/A ratioratio of the maximal velocity of E (early LV filling) and A (atrial contraction) waves; (2) E-wave deceleration time (DT)the time from the peak of the E wave to the intersection of the deceleration slope of the E wave with the baseline; and (3) LV isovolumic relaxation time (IVRT), which was measured from the aortic valve closure to the mitral valve opening.17,18 The M-mode and Doppler tracings were conducted with a paper speed of 200 mm/sec.
Blood Gas Analysis
Blood gas analysis was performed using IL Synthesis Systems (Instrumentation Laboratory, 1998, Milano, Italy). The right carotid artery or left femoral artery was dissected, and a polyethylene catheter (PE-10) was inserted into the artery up to the aortic arch. Four mice in each group were anesthetized as described above and exposed to 100% O2, and 3 mice in each group were ventilated with 35% CO2. Approximately 0.3 mL of blood was drawn into a syringe for measurement of arterial blood pH after 40 minutes of ventilation with either 100% oxygen or 35% CO2 balanced with oxygen. During the exposure to either gas, LV function was monitored by ECHO.
Electrophoresis and Western Blot Analysis
TnI Phosphorylation
The apex of the left ventricle was placed directly into 10% TCA in acetone (70°C) and placed in the 70°C freezer for a minimum of 16 hours. Samples were slowly warmed to room temperature (1 hour at 20°C, 1 hour at 4°C, and 1 hour at room temperature) to allow acetone substitution of the tissue, preserving the phosphorylation status of the proteins. TnI phosphorylation was analyzed by nonequilibrium 1D isoelectric focusing as described previously.19 Percentage phosphorylation was expressed as TnI (phosphorylated)/(TnI [dephosphorylated]+TnI [phosphorylated])x100%.
Expression of SERCA2 and Phospholamban Phosphorylation
Hearts were frozen in liquid nitrogen and stored at 80°C. Samples were homogenized in modified radioimmunoprecipitation assay buffer with protease and phosphatase inhibitors (Upstate). SDS-PAGE was performed using 8% acrylamide gels (SERCA2a) and 4% to 20% acrylamide gradient gels (phospholamban [PLB]). Proteins were transferred to nitrocellulose membranes, blocked with 5% nonfat milk, and incubated with anti-PLB (1:2000; Upstate), antiphospho-PLB Ser16 (Upstate; 1:1000), antiphospho-PLB Thr17 (1:2500; Badrilla-UK) or anti-SERCA2a (1:2000; ABR) antibodies. Following incubation with primary antibody, membranes were incubated in horseradish peroxidasecoupled secondary antibodies (Amersham) (1:5000 for antiphospho-PLB and 1:10000 for anti-PLB and anti-SERCA2a) followed by ECL detection (Pierce). Membranes incubated initially in antiphospho-PLB antibody were stripped using a commercial stripping buffer (Pierce), and the same membranes were probed using an anti-PLB antibody. To assess the levels of expression of PLB and SERCA2a, densitometric analysis (Personal densitometer; Amershan Biosciences) was performed using the DataQuaNT software.
Statistical Analysis
All results are presented as mean±SE. The statistical significance of differences between groups of NTG and TG mice was determined by one-way or one-way repeated-measures ANOVA followed by the StudentNewmanKeuls test, as appropriate. A value of P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
Diastolic function was assessed using the pulsed Doppler ECHO. Figure 2 shows the E-to-A wave ratios (E/A) (Figure 2A), E-wave DTs (Figure 2B) and LV isovolumic relaxation times (IVRT) (Figure 2C) at 20 minutes of baseline conditions, 20 minutes of hypercapnic acidosis, and 20 minutes of recovery. At all time points during the experiments, the E/A ratios were significantly lower in TG compared with NTG hearts. In TG mice, the E-wave DT was prolonged at 20 minutes of baseline conditions and 20 minutes of hypercapnic acidosis (Figure 2B). LV IVRT was the same in NTG and TG mice during baseline conditions but was longer in TG compared with NTG at 20 minutes of 35% CO2 (Figure 2C). In TG hearts, LV IVRT was longer at 20 minutes of CO2 than in baseline and recovery conditions. Figure 2D shows representative examples of pulsed Doppler mitral flow recordings in NTG and TG mice at baseline level and at 20 minutes of 35% CO2. At baseline the E/A ratios were 1.3 in NTG and 1.0 in TG hearts and at 20 minutes of CO2, decreased to 1.2 in NTG and 0.9 in TG hearts, respectively. E-wave DT was 25 ms in NTG and 31 ms in TG hearts at baseline and decreased to 21 ms in NTG and 29 ms in TG hearts at 20 minutes of CO2. LV IVRTs were the same at baseline (15 ms in NTG and 15 ms in TG hearts) but at 20 minutes of CO2, increased only in TG heart to 23 ms.
|
Effect of Hypercapnic Acidosis on LV Systolic and Diastolic Functions in the Presence of Propranolol
To determine whether the response from the sympathetic nervous system is critical for the survival of NTG and TG mice during the hypercapnic conditions, we blocked the ß-adrenergic receptors by continuous infusion of propranolol. As illustrated in Figure 3A, in the presence of propranolol (at 20 minutes of propranolol), FS decreased from a baseline (20 minutes of O2) value 42.0±1.9% to 25.2±1.9% in NTG mice (n=5) and from 51.6±3.4% to 27.6±2.8% in TG mice (n=5). In NTG mice, switching to 35% CO2 resulted in a precipitous, sudden decrease in FS, and by 4 minutes all 5 NTG mice had died. However, in TG mice, FS decreased only slightly initially, and during 15 to 20 minutes of hypercapnic acidosis, they recovered fully to the baseline level. After switching back to 100% oxygen, FS transiently increased to 68.0±1.5% (5 minutes of recovery) and then returned to a level slightly below FS in baseline conditions. Figure 3B presents M-mode ECHO recordings of the LV in NTG and TG mice during exposure to hypercapnic acidosis in the presence of propranolol. The image of the LV in the NTG mouse was taken at the moment of death, 4 minutes after switching to 35% CO2. Under the same conditions, however, there was normal LV systolic function in TG mouse. The M-mode ECHO recordings of LV in TG mouse is presented 7 minutes after the onset of ventilation with 35% CO2.
|
The effects of propranolol on LV diastolic function of TG mice are presented in Figure 4. There was no difference in the E/A ratio between the TG mice with and without propranolol (Figure 4A). In the presence of propranolol at 20 minutes of CO2, E-wave DT was significantly prolonged compared with E-wave DT at 20 minutes of CO2 without propranolol and with baseline and recovery (with and without propranolol) (Figure 4B). Infusion with propranolol also resulted in prolongation of LV IVRT (Figure 4C).
|
Table 1 summarizes the effect of hypercapnic acidosis on heart rate (HR) in the presence and absence of propranolol. In surviving mice, HR was not significantly different between TG and NTG groups under any experimental condition. Infusion of propranolol resulted in significant decreases in HRs in NTG and TG mice.
|
Blood Gas Analysis During Hypercapnic Acidosis
Under baseline conditions blood pH, PCO2, and PO2 were not different between NTG and TG animals (Table 2). Hypercapnic acidosis resulted in a significant decrease in blood pH, an increase in PCO2 and a decrease in PO2 in both groups of animals (Table 2), but there was no significant difference between NTG and TG animals.
|
Effect of Hypercapnic Acidosis on TnI and PLB Phosphorylation
Because hypercapnia is associated with stimulation of the sympathetic nervous system and activation of protein kinases, in the next series of experiments we determined the states of TnI and PLB phosphorylation in NTG and TG groups of mice during the baseline condition and during hypercapnia (4 minutes of CO2) in the presence and absence of propranolol. The results shown in Figure 5 demonstrate that cTnI appears in an unphosphorylated and three phosphorylated (P1, P2, and P3) species. NTG mice subjected to 35% CO2 show a significantly increased level of cTnI phosphorylation that is prevented by propranolol. However, as expected, there were no changes in ssTnI phosphorylation in any of the experimental conditions (data not shown).
|
Figure 6A and 6B show phosphorylation of Ser16 and Thr17 of PLB in TG (lanes 1 to 4) and NTG (lanes 5 to 8) hearts at baseline (20 minutes of O2) (lanes 1 and 5), 20 minutes of propranolol (lanes 2 and 6), 20 minutes of hypercapnic acidosis (lanes 3 and 7), and at 4 minutes of hypercapnic acidosis in the presence of propranolol (lanes 4 and 8). In the baseline condition, the phosphorylation of Ser16 was low (2 of 3 samples) or not detectable (1 sample). Phosphorylation of Thr17 was not detectable in any of the three baseline samples. In the absence of propranolol, hypercapnia resulted in an increase in phosphorylation of Ser16 and Thr17 in both groups of animals. The hypercapnia-induced increase in phosphorylation of Ser16 and Thr17 was completely prevented by propranolol. Figure 6C shows that the level of expression of PLB was not different between TG (lanes 1 to 4) and NTG (lanes 5 to 8) mice. There was no change in the expression levels of SERCA2a between NTG and TG groups (data not shown).
|
| Discussion |
|---|
|
|
|---|
Differences in the response to acidic pH among various types of muscles lie in the isoforms of myofilament proteins. Donaldson et al20 reported the first evidence that effects of acidosis on Ca2+-force relations of isolated myofilaments differ among fast, slow, and cardiac muscle. Early studies also demonstrated that Ca2+ activation of neonatal heart myofilaments is relatively insensitive to deactivation by acidic pH, when compared with adult myofilaments,2 and that this differential effect is localized in thin filament proteins.1 With identification of ssTnI as the neonatal isoform,21 we set out to determine whether this isoform switch is responsible for the differential effect of acidosis.7 Definitive evidence that this is indeed the case came from investigations of myofilaments from TG mice in which ssTnI completely replaced cTnI.8 Wolska et al8 reported that Ca2+-force relations of skinned fiber bundles from hearts of the ssTnI-TG mice were less right shifted in acidosis than the NTG controls. With acidosis, there was also a significant and sustained fall in tension of electrically stimulated NTG papillary muscles but no effect in the TG muscles.
Various regions of TnI have been proposed to be responsible for the differential response to acidic pH between ssTnI and cTnI. Studies using different chimeras composed of regions of cTnI and ssTnI suggest that a pH-sensitive domain may reside in the carboxyl terminus9 or in the inhibitory portion of TnI.10 However, more recent studies have localized a specific amino acid (Ala162) of cTnI as largely responsible for the differential response to acidosis.5 When Ala162 was replaced with His (the corresponding ssTnI amino acid), the Ca2+ sensitivity of ATPase activity of reconstituted myofilament preparations at pH 6.5 was restored to that at pH 7.0. An important question, which we have addressed here, is the relative significance of these changes in hearts in vivo. Apart from the differences between ssTnI and cTnI in their response to acidosis, there are other differences between the two isoforms that may play a role in the ability of ssTnI to protect the myocardium from deactivation by acidic pH. One major difference between cTnI and ssTnI is the presence of a 32-amino acid N-terminal extension in cTnI.22 This extension contains 2 serines at positions 22 and 23, which are phosphorylated by protein kinase A.23 Phosphorylation of these sites results in a decrease in myofilament sensitivity to Ca2+ and contributes to the enhanced rate of relaxation in situ during ß-adrenergic stimulation.12,14,24
During acidosis, in the absence of the ß-adrenergic blocker propranolol, we observed the complete recovery of FS in NTG hearts and an increase in FS in TG hearts. The mechanical recovery during acidosis has been previously reported by us8 and others6,25,26 and can be explained by partial recovery of intracellular pH and/or an increase in Ca2+ transient amplitude attributable to increased sarcoplamic reticulum (SR) Ca2+ load as a consequence of increased activity of Na+/H+ exchanger, inhibition of Na+/K+ pump, and phosphorylation of PLB. Our current data demonstrate that acidosis in the absence of propranolol significantly increases the level of phosphorylation of PLB (Figure 6). The phosphorylation of PLB releases SERCA2a inhibition and results in an increased SR Ca2+ uptake and increased Ca2+ transient. However, at the same time, acidic pH directly suppresses the SR CaATPase activity; therefore, the net effect of SERCA2a activity depends on multiple factors. It has been reported in isolated cells that the Ca2+ transient is significantly increased not only during acidosis but also stays elevated after switching to solutions with normal pH.6,27 Small transient increases above the baseline value (before acidosis) in intracellular pH have also been reported during the first few minutes after switching to control solution.6,27,28 These alterations in pH and Ca2+ transients can significantly influence the recovery kinetics of FS and may have more profound effects on TG mice because their myofilaments are more sensitive to Ca2+.8 During recovery, intracellular pH comes to a baseline value faster than dephosphorylation of PLB and myofilament regulatory proteins that were phosphorylated during hypercapnic acidosis. In Langendorff perfused hearts stimulated with isoproterenol, cTnI stayed phosphorylated after 15 minutes perfusion with drug-free solution, whereas, at the same time, PLB was almost completely dephosphorylated.29
Our data indicate that during hypercapnic conditions in situ, reflex activation of the sympathetic nervous system is critical for survival of NTG mice. Because we used propranolol, a specific ß-adrenergic receptor blocker, the increase in the FS during hypercapnic acidosis in TG mice is most likely attributable to stimulation of
-adrenergic receptors, an increase in Ca2+ transient amplitude, and partial recovery of intracellular pH. Stimulation of
-adrenergic receptors by phenylephine in Langendorff perfused mouse hearts in the presence of a ß-blocker results in positive inotropic effect.30,31 Moreover, it has been demonstrated in swine that acute hypercapnia was associated with release of both norepinephrine and epinephrine.32 Plasma norepinephrine concentration increased 3.4-fold and epinephrine increased 1.8-fold compared with basal concentrations. A similar increase in catecholamine levels was most likely present in our experimental conditions. Our functional (ECHO) and biochemical (TnI and PLB phosphorylation) data indicate that during hypercapnic conditions, there is a significant release of catecholamines that stimulate both adrenergic receptors in the absence of propranolol and
-adrenergic receptors in the presence of propranolol. In NTG hearts, which demonstrate a more significant reduction of myofilament sensitivity to Ca2+ during acidosis than TG hearts, the contribution of
-receptors is apparently too small to prevent mice from death. Interestingly, in the presence of propranolol, acidosis decreases HR in TG mice, despite an increase in FS. In these conditions, HR is a net result of at least two opposite effects: stimulation of
-adrenergic receptors and acidification, which is known to decrease the frequency of spontaneous beating of the sino-atrial node.33
The rate of cardiac relaxation is influenced by both myofilament properties and Cai2+ decay. We have previously shown in vitro that myofilaments from TG mice expressing ssTnI demonstrate higher myofilament sensitivity to Ca2+ that resulted in an impairment of diastolic function in TG mice.8,14 This was confirmed in the experiments reported here and manifested by a smaller E/A ratio and longer E-wave DT in TG mice compared with NTG mice. Acidosis in situ is associated with release of catecholamines and stimulation of adrenergic receptors. Stimulation of ß-adrenergic receptors results in phosphorylation of multiple proteins in the sarcolemma, SR, and myofilaments.13,34 Phosphorylation of PLB appears to be the most dominant among the proteins responsible for the enhanced rate of relaxation; however, the role of cTnI phosphorylation cannot be excluded.12 Our data show that in the absence of propranolol, hypercapnic acidosis induced a significant increase in cTnI phosphorylation in NTG hearts and increased phosphorylation of Ser16 and Thr17 of PLB in both groups. Additionally in NTG hearts, phosphorylation of cTnI contributes to enhanced rate of relaxation. At the same time, acidic pH directly inhibits SERCA2a activity. Therefore, the overall effect of hypercapnic acidosis on the rate of relaxation in situ is the net result of multiple factors. Based on ECHO relaxation parameters during hypercapnia, the relaxation was significantly impaired in TG compared with NTG hearts. This is most likely attributable to smaller desensitization of myofilaments in TG compared with NTG hearts. Our previous studies have indicated that ventricular myocytes isolated from TG hearts exhibit no major differences in Ca2+ transients from myocytes isolated from NTG hearts, both in control conditions and during isoproterenol stimulation.14 We have also reported13 data that show that the expression and distribution of ß1 and ß2 receptors are not different between NTG and TG hearts. Therefore, we do not anticipate a significantly different response of the sympathetic nervous system to acidosis between NTG and TG mice. Moreover, there were no differences between NTG and TG hearts in isoform population of myosin or thin filament proteins other than TnI that could account for the differential response to hypercapnic conditions.
In summary, data presented here strongly support the hypothesis that myofilament deactivation by acidosis is the major factor responsible for depression of contractility in acidosis. These data indicate that ssTnI, which is expressed in fetal and neonatal myocardium, plays a critical function in protecting immature hearts in acidic conditions from significant decreases in contractility caused by myofilament desensitization. Our data also support the more general hypothesis that alteration in myofilament response to Ca2+ is a major variable affecting cardiac function.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Solaro RJ, Lee JA, Kentish JC, Allen DG. Effects of acidosis on ventricular muscle from adult and neonatal rats. Circ Res. 1988; 63: 779787.
3. Hunkeler NM, Kullman J, Murphy AM. Troponin I isoform expression in human heart. Circ Res. 1991; 69: 14091414.
4. Murphy AM, Jones L, Sims HF, Strauss AW. Molecular cloning of rat cardiac troponin I and analysis of troponin I isoform expression in developing rat heart. Biochemistry. 1991; 30: 707712.[CrossRef][Medline] [Order article via Infotrieve]
5. Dargis R, Pearlstone JR, Barrette-Ng I, Edwards H, Smillie LB. Single mutation (A162H) in human cardiac troponin I corrects acid pH sensitivity of Ca2+-regulated actomyosin S1 ATPase. J Biol Chem. 2002; 277: 3466234665.
6. Nakanishi T, Seguchi M, Tsuchiya T, Yasukouchi S, Takao A. Effect of acidosis on intracellular pH and calcium concentration in the newborn and adult rabbit myocardium. Circ Res. 1990; 67: 111123.
7. Martin AF, Ball K, Gao LZ, Kumar P, Solaro RJ. Identification and functional significance of troponin I isoforms in neonatal rat heart myofibrils. Circ Res. 1991; 69: 12441252.
8. Wolska BM, Vijayan K, Arteaga GM, Konhilas JP, Phillips RM, Kim R, Naya T, Leiden JM, Martin AF, de Tombe PP, Solaro RJ. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol. 2001; 536: 863870.
9. Westfall MV, Albayya FP, Turner II, Metzger JM. Chimera analysis of troponin I domains that influence Ca2+-activated myofilament tension in adult cardiac myocytes. Circ Res. 2000; 86: 470477.
10. Li G, Martin AF, Solaro RJ. Localization of regions of troponin I important in deactivation of cardiac myofilaments by acidic pH. J Mol Cell Cardiol. 2001; 33: 13091320.[CrossRef][Medline] [Order article via Infotrieve]
11. Layland J, Grieve DJ, Cave AC, Sparks E, Solaro RJ, Shah AM. Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically. J Physiol. 2004; 556: 835847.
12. Pena JR, Wolska BM. Troponin I phosphorylation plays an important role in the relaxant effect of ß-adrenergic stimulation in mouse hearts. Cardiovasc Res. 2004; 61: 756763.[CrossRef][Medline] [Order article via Infotrieve]
13. Wolska BM, Arteaga GM, Pena JR, Nowak G, Phillips RM, Sahai S, de Tombe PP, Martin AF, Kranias EG, Solaro RJ. Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of ß-adrenergic stimulation. Circ Res. 2002; 90: 882888.
14. Fentzke RC, Buck SH, Patel JR, Lin H, Wolska BM, Stojanovic MO, Martin AF, Solaro RJ, Moss RL, Leiden JM. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol. 1999; 517: 143157.
15. Pena JR, Wolska BM. Differential effects of isoflurane and ketamine/inactin anesthesia on cAMP and cardiac function in FVB/N mice during basal state and ß-adrenergic stimulation. Basic Res Cardiol. 2005; 100: 147153.[CrossRef][Medline] [Order article via Infotrieve]
16. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58: 10721083.
17. Feigenbaum H, Armstrong WF, Ryan T. Evaluation of systolic and diastolic function of the left ventricle. In: Feigenbaum H, Armstrong WF, Ryan T, eds. Feigenbaum s Echocardiography. Baltimore, Md: Lippincott Williams and Wilkins; 2005: 138180.
18. Schmidt AG, Gerst M, Zhai J, Carr AN, Pater L, Kranias EG, Hoit BD. Evaluation of left ventricular diastolic function from spectral and color M-mode Doppler in genetically altered mice. J Am Soc Echocardiogr. 2002; 15: 10651073.[CrossRef][Medline] [Order article via Infotrieve]
19. Kobayashi T, Yang X, Walker LA, Van Breemen RB, Solaro RJ. A nonequilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C. J Mol Cell Cardiol. 2005; 38: 213218.[CrossRef][Medline] [Order article via Infotrieve]
20. Donaldson SK, Hermansen L, Bolles L. Differential, direct effects of H+ on Ca2+-activated force of skinned fibers from the soleus, cardiac and adductor magnus muscles of rabbits. Pflugers Arch. 1978; 376: 5565.[CrossRef][Medline] [Order article via Infotrieve]
21. Saggin L, Gorza L, Ausoni S, Schiaffino S. Troponin I switching in the developing heart. J Biol Chem. 1989; 264: 1629916302.
22. Leszyk J, Dumaswala R, Potter JD, Collins JH. Amino acid sequence of bovine cardiac troponin I. Biochemistry. 1988; 27: 28212827.[CrossRef][Medline] [Order article via Infotrieve]
23. Swiderek K, Jaquet K, Meyer HE, Heilmeyer LMG. Cardiac troponin I, isolated from bovine heart, contains two adjacent phosphoserines. A first example of phosphoserine determination by derivatization to S-ethylcysteine. Eur J Biochem. 1988; 176: 335342.[Medline] [Order article via Infotrieve]
24. Zhang R, Zhao J, Potter JD. Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C. J Biol Chem. 1995; 270: 3077330780.
25. Cingolani HE, Koretsune Y, Marban E. Recovery of contractility and pH during respiratory acidosis in ferret hearts: role of Na/H exchange. Am J Physiol. 1990; 259: H843H848.[Medline] [Order article via Infotrieve]
26. Mundina-Weilenmann C, Ferrero P, Said M, Vittone L, Kranias EG, Mattiazzi A. Role of phosphorylation of Thr(17) residue of phospholamban in mechanical recovery during hypercapnic acidosis. Cardiovasc Res. 2005; 66: 114122.[CrossRef][Medline] [Order article via Infotrieve]
27. Harrison SM, Frampton JE, McCall E, Boyett MR, Orchard CH. Contraction and intracellular Ca2+, Na+, and H+ during acidosis in rat ventricular myocytes. Am J Physiol. 1992; 262: C348C357.[Medline] [Order article via Infotrieve]
28. Nomura N, Satoh H, Terada H, Matsunaga M, Watanabe H, Hayashi H. CaMKII-dependent reactivation of SR Ca2+ uptake and contractile recovery during intracellular acidosis. Am J Physiol Heart. 2002; 283: H193H203.
29. Garvey JL, Kranias EG, Solaro RJ. Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. Biochem J. 1988; 249: 709714.[Medline] [Order article via Infotrieve]
30. Ross SA, Rorabaugh BR, Chalothorn D, Yun J, Gonzalez-Cabrera PJ, McCune DF, Piascik MT, Perez DM. The
1B-adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model. Cardiovasc Res. 2003; 60: 598607.
31. Petrashevskaya NN, Bodi I, Koch SE, Akhter SA, Schwartz A. Effects of alpha1-adrenergic stimulation on normal and hypertrophied mouse hearts. Relation to caveolin-3 expression. Cardiovasc Res. 2004; 63: 561572.
32. Brofman JD, Leff AR, Munoz NM, Kirchhoff C, White SR. Sympathetic secretory response to hypercapnic acidosis in swine. J Appl Physiol. 1990; 69: 710717.
33. Satoh H, Seyama I. On the mechanism by which changes in extracellular pH affect the electrical activity of the rabbit sino-atrial node. J Physiol. 1986; 381: 181191.
34. Luo WS, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of ß-agonist stimulation. Circ Res. 1994; 75: 401409.
This article has been cited by other articles:
![]() |
N. J. Palpant, L. G. D'Alecy, and J. M. Metzger Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo FASEB J, May 1, 2009; 23(5): 1529 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Palpant, S. M. Day, T. J. Herron, K. L. Converso, and J. M. Metzger Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction Cardiovasc Res, November 1, 2008; 80(2): 209 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yuan, Q. Sheng, H. Tang, Y. Li, R. Zeng, and R. J. Solaro Quantitative comparison of sarcomeric phosphoproteomes of neonatal and adult rat hearts Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H647 - H656. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-Q. Huang, H. Z. Feng, J. Liu, J. Du, L. B. Stull, C. S. Moravec, X. Huang, and J.-P. Jin Co-expression of skeletal and cardiac troponin T decreases mouse cardiac function Am J Physiol Cell Physiol, January 1, 2008; 294(1): C213 - C222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, J. Du, C. Zhang, J. W. Walker, and X. Huang Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1273 - H1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bupha-Intr, J. Wattanapermpool, J. R. Pena, B. M. Wolska, and R. J. Solaro Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R837 - R843. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Engel, T. Kobayashi, B. Biesiadecki, J. Davis, S. Tikunova, S. Wu, and R. J. Solaro Identification of a Region of Troponin I Important in Signaling Cross-bridge-dependent Activation of Cardiac Myofilaments J. Biol. Chem., January 5, 2007; 282(1): 183 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cazorla, S. Szilagyi, N. Vignier, G. Salazar, E. Kramer, G. Vassort, L. Carrier, and A. Lacampagne Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice Cardiovasc Res, February 1, 2006; 69(2): 370 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kass and R. J. Solaro Mechanisms and Use of Calcium-Sensitizing Agents in the Failing Heart Circulation, January 17, 2006; 113(2): 305 - 315. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |